Total Payments
$257,345
2024 Payments
$87,173
Companies
11
Transactions
364
Payment Breakdown by Category
Consulting$134,877 (52.4%)
Research$86,209 (33.5%)
Travel$27,589 (10.7%)
Other$4,250 (1.7%)
Food & Beverage$2,677 (1.0%)
Education$1,744 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $134,877 | 54 | 52.4% |
| Unspecified | $86,209 | 170 | 33.5% |
| Travel and Lodging | $27,589 | 88 | 10.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,250 | 7 | 1.7% |
| Food and Beverage | $2,677 | 41 | 1.0% |
| Education | $1,744 | 4 | 0.7% |
Payments by Type
General
$171,136
194 transactions
Research
$86,209
170 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $150,226 | 279 | $0 (2024) |
| GENZYME CORPORATION | $34,483 | 12 | $0 (2024) |
| Shire North American Group Inc | $14,344 | 14 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $12,785 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $12,637 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,295 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $9,142 | 9 | $0 (2024) |
| Adare Pharmaceuticals, Inc. | $5,894 | 10 | $0 (2020) |
| Celgene Corporation | $4,124 | 10 | $0 (2024) |
| AstraZeneca UK Limited | $1,167 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87,173 | 154 | Regeneron Pharmaceuticals, Inc. ($59,217) |
| 2023 | $44,063 | 58 | Regeneron Pharmaceuticals, Inc. ($28,772) |
| 2022 | $40,274 | 44 | Regeneron Pharmaceuticals, Inc. ($27,786) |
| 2021 | $21,084 | 23 | GENZYME CORPORATION ($6,162) |
| 2020 | $26,951 | 41 | Regeneron Pharmaceuticals, Inc. ($8,184) |
| 2019 | $12,452 | 14 | Regeneron Pharmaceuticals, Inc. ($7,414) |
| 2018 | $10,500 | 20 | Shire North American Group Inc ($4,561) |
| 2017 | $14,849 | 10 | Regeneron Pharmaceuticals, Inc. ($9,974) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $599.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $550.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $514.99 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $378.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $375.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $362.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $281.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $258.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $86.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $73.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $61.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $60.95 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $55.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $53.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $44.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $36.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $34.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $26.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $26.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $18.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $18.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $15.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS | Regeneron Pharmaceuticals, Inc. | $35,429 | 66 |
| A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) | Regeneron Pharmaceuticals, Inc. | $32,716 | 58 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $6,851 | 10 |
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF DUPILUMAB IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS | Regeneron Pharmaceuticals, Inc. | $5,778 | 17 |
| A Randomized, Double-Blind, Parallel, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis | Regeneron Pharmaceuticals, Inc. | $2,154 | 9 |
| A Phase 3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis EoE | Regeneron Pharmaceuticals, Inc. | $1,196 | 5 |
| HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) | Regeneron Pharmaceuticals, Inc. | $999.50 | 1 |
| A Phase 2/3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis | Regeneron Pharmaceuticals, Inc. | $852.95 | 3 |
| A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS | Regeneron Pharmaceuticals, Inc. | $231.46 | 1 |
About Dr. Mirna Chehade, M.D
Dr. Mirna Chehade, M.D is a Pediatric Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447229190.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mirna Chehade, M.D has received a total of $257,345 in payments from pharmaceutical and medical device companies, with $87,173 received in 2024. These payments were reported across 364 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($134,877).
Ad
Practice Information
- Specialty Pediatric Gastroenterology
- Other Specialties Pediatrics
- Location New York, NY
- Active Since 03/15/2006
- Last Updated 03/26/2013
- Taxonomy Code 2080P0206X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1447229190
Products in Payments
- DUPIXENT (Biological) $166,113
- DUPIXENT DUPILUMAB INJECTION (Biological) $12,913
- FASENRA (Biological) $3,880
- EOHILIA (Drug) $2,670
- TEZSPIRE (Biological) $2,283
- Fluticasone propionate Orodispersible Tablet $2,125
- FASENRA (Drug) $1,373
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Gastroenterology Doctors in New York
Dr. Sivan Kinberg, M.d, M.D
Pediatric Gastroenterology — Payments: $212,386
Pediatric Gastroenterology $212,386
Neal Leleiko, Md, MD
Pediatric Gastroenterology — Payments: $184,814
Pediatric Gastroenterology $184,814
Dr. Nadia Ovchinsky
Pediatric Gastroenterology — Payments: $51,472
Pediatric Gastroenterology $51,472
John Bucuvalas, M.d, M.D
Pediatric Gastroenterology — Payments: $13,559
Pediatric Gastroenterology $13,559
Dr. Julie Khlevner, Md, MD
Pediatric Gastroenterology — Payments: $10,057
Pediatric Gastroenterology $10,057
Dr. Esi Sama Lamouse-Smith, Md, Phd, MD, PHD
Pediatric Gastroenterology — Payments: $7,799
Pediatric Gastroenterology $7,799